These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 14579092)

  • 21. Characterization of the radioactive metabolites of the 5-HT1A receptor radioligand, [O-methyl-11C]WAY-100635, in monkey and human plasma by HPLC: comparison of the behaviour of an identified radioactive metabolite with parent radioligand in monkey using PET.
    Osman S; Lundkvist C; Pike VW; Halldin C; McCarron JA; Swahn CG; Ginovart N; Luthra SK; Bench CJ; Grasby PM; Wikström H; Barf T; Cliffe IA; Fletcher A; Farde L
    Nucl Med Biol; 1996 Jul; 23(5):627-34. PubMed ID: 8905828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of cyclosporin A administration on the biodistribution and multipinhole muSPECT imaging of [123I]R91150 in rodent brain.
    Blanckaert P; Burvenich I; Staelens S; De Bruyne S; Moerman L; Wyffels L; De Vos F
    Eur J Nucl Med Mol Imaging; 2009 Mar; 36(3):446-53. PubMed ID: 18985346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Absolute quantitation of iodine-123 epidepride kinetics using single-photon emission tomography: comparison with carbon-11 epidepride and positron emission tomography.
    Almeida P; Ribeiro MJ; Bottlaender M; Loc'h C; Langer O; Strul D; Hugonnard P; Grangeat P; Mazière B; Bendriem B
    Eur J Nucl Med; 1999 Dec; 26(12):1580-8. PubMed ID: 10638410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of the SPECT 5-HT2A receptor ligand 123I-R91150 in healthy volunteers: Part 1--pseudoequilibrium interval and quantification methods.
    Catafau AM; Danus M; Bullich S; Llop J; Perich J; Cunningham VJ; Plaza P; Penengo MM; Eersels JL; Squassante L; Ros D; Barbanoj M
    J Nucl Med; 2006 Jun; 47(6):919-28. PubMed ID: 16741300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and evaluation of nicotine alpha4beta2 receptor radioligand, 5-(3'-18F-fluoropropyl)-3-(2-(S)-pyrrolidinylmethoxy)pyridine, in rodents and PET in nonhuman primate.
    Chattopadhyay S; Xue B; Collins D; Pichika R; Bagnera R; Leslie FM; Christian BT; Shi B; Narayanan TK; Potkin SG; Mukherjee J
    J Nucl Med; 2005 Jan; 46(1):130-40. PubMed ID: 15632043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Whole-body biodistribution and dosimetry estimates of a novel radiotracer for imaging of serotonin 4 receptors in brain: [¹⁸F]MNI-698.
    Tavares AA; Caillé F; Barret O; Papin C; Lee H; Morley TJ; Fowles K; Holden D; Seibyl JP; Alagille D; Tamagnan GD
    Nucl Med Biol; 2014; 41(5):432-9. PubMed ID: 24674817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiolabeling and in vitro and in vivo evaluation of [18F]-FE-DABP688 as a PET radioligand for the metabotropic glutamate receptor subtype 5.
    Honer M; Stoffel A; Kessler LJ; Schubiger PA; Ametamey SM
    Nucl Med Biol; 2007 Nov; 34(8):973-80. PubMed ID: 17998101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of [11C]PipISB and [18F]PipISB in monkey as candidate radioligands for imaging brain cannabinoid type-1 receptors in vivo.
    Finnema SJ; Donohue SR; Zoghbi SS; Brown AK; Gulyás B; Innis RB; Halldin C; Pike VW
    Synapse; 2009 Jan; 63(1):22-30. PubMed ID: 18925657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pyridinyl-6 position of WAY-100635 as a site for radiofluorination--effect on 5-HT1A receptor radioligand behavior in vivo.
    McCarron JA; Pike VW; Halldin C; Sandell J; Sóvágó J; Gulyas B; Cselényi Z; Wikström HV; Marchais-Oberwinkler S; Nowicki B; Dollé F; Farde L
    Mol Imaging Biol; 2004; 6(1):17-26. PubMed ID: 15018825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiosynthesis and in vivo evaluation of novel radioligands for PET imaging of cerebral 5-HT7 receptors.
    Hansen HD; Herth MM; Ettrup A; Andersen VL; Lehel S; Dyssegaard A; Kristensen JL; Knudsen GM
    J Nucl Med; 2014 Apr; 55(4):640-6. PubMed ID: 24566002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain and whole-body imaging in rhesus monkeys of 11C-NOP-1A, a promising PET radioligand for nociceptin/orphanin FQ peptide receptors.
    Kimura Y; Fujita M; Hong J; Lohith TG; Gladding RL; Zoghbi SS; Tauscher JA; Goebl N; Rash KS; Chen Z; Pedregal C; Barth VN; Pike VW; Innis RB
    J Nucl Med; 2011 Oct; 52(10):1638-45. PubMed ID: 21880575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new positron emission tomography imaging agent for the serotonin transporter: synthesis, pharmacological characterization, and kinetic analysis of [11C]2-[2-(dimethylaminomethyl)phenylthio]-5-fluoromethylphenylamine ([11C]AFM).
    Huang Y; Hwang DR; Bae SA; Sudo Y; Guo N; Zhu Z; Narendran R; Laruelle M
    Nucl Med Biol; 2004 Jul; 31(5):543-56. PubMed ID: 15219271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics and brain distribution in non human primate of R(-)[123I]DOI, A 5HT(2A/2C) serotonin agonist.
    Zea-Ponce Y; Kegeles LS; Guo N; Raskin L; Bakthavachalam V; Laruelle M
    Nucl Med Biol; 2002 Jul; 29(5):575-83. PubMed ID: 12088728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo evaluation in rodents of [(123)I]-3-I-CO as a potential SPECT tracer for the serotonin 5-HT(2A) receptor.
    Blanckaert PB; Burvenich I; Wyffels L; De Bruyne S; Moerman L; De Vos F
    Nucl Med Biol; 2008 Nov; 35(8):861-7. PubMed ID: 19026947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbon-11 pb-12: an attempt to visualize the dopamine d(4) receptor in the primate brain with positron emission tomography.
    Langer O; Halldin C; Chou Y; Sandell J; Swahn C; Någren K; Perrone R; Berardi F; Leopoldo M; Farde L
    Nucl Med Biol; 2000 Nov; 27(8):707-14. PubMed ID: 11150701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and evaluation of [11C]FR194921 as a nonxanthine-type PET tracer for adenosine A1 receptors in the brain.
    Matsuya T; Takamatsu H; Murakami Y; Noda A; Ichise R; Awaga Y; Nishimura S
    Nucl Med Biol; 2005 Nov; 32(8):837-44. PubMed ID: 16253808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The new PET imaging agent [11C]AFE is a selective serotonin transporter ligand with fast brain uptake kinetics.
    Zhu Z; Guo N; Narendran R; Erritzoe D; Ekelund J; Hwang DR; Bae SA; Laruelle M; Huang Y
    Nucl Med Biol; 2004 Nov; 31(8):983-94. PubMed ID: 15607480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of PET ligands (+)N-[(11)C]ethyl-3-piperidyl benzilate and (+)N-[(11)C]propyl-3-piperidyl benzilate for muscarinic cholinergic receptors: a PET study with microdialysis in comparison with (+)N-[(11)C]methyl-3-piperidyl benzilate in the conscious monkey brain.
    Nishiyama S; Tsukada H; Sato K; Kakiuchi T; Ohba H; Harada N; Takahashi K
    Synapse; 2001 Jun; 40(3):159-69. PubMed ID: 11304753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PET-examination and metabolite evaluation in monkey of [(11)C]NAD-299, a radioligand for visualisation of the 5-HT(1A) receptor.
    Sandell J; Halldin C; Chou YH; Swahn CG; Thorberg SO; Farde L
    Nucl Med Biol; 2002 Jan; 29(1):39-45. PubMed ID: 11786274
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.